TELA Bio, Inc.

US$0.82As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TELAHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (33.42%)
Div yield —
ROE —
Medical Devices
Beta (5Y) 1.46
PE TTM —
TSR TTM (33.33%)
Mkt cap US$37.02M
ROIC (45.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.06
29.51%
204.99%
Hold 4|9|5|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
36.64%
35.33%
34.58%
25.31%
Revenue$M
2.100
2.134
2.074
2.140
5.15%
4.99%
2.64%
2.25%
Peers (US$37.02M)
Cap (US$)
PE
37.09M
0.671x
37.22M
10.95x
Capital
TTM
5Y
10Y
Leveragex
0.626
0.388
0.341
EBIT/Intx
0.334
0.386
0.357
Own earn%
(55.38)
(1.14)
(4.11)
Sh yield%
22.27
28.22
26.83
Owners
Insiders/Inst%
4.76
81.75
Short interest%
3.89
SBC / revenue%
5.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
4–8
$1 testx
—
Incr. ROIC%
7